ConductScience.org, home

Paper32065026

Estimating Social Variation in the Health Effects of Changes in Health Care Expenditure.

Love-Koh J and 3 others. Med Decis Making, 2020. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Estimating Social Variation in the Health Effects of Changes in Health Care Expenditure. Papers, record 32065026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32065026

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Estimating Social Variation in the Health Effects of Changes in Health Care Expenditure.
PubMed
Journal
Med Decis Making
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
2.62
iCite
Revised in PubMed
2024-03-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Love-Koh JJameshttps://orcid.org/0000-0001-9009-5346
2Cookson RRichard
3Claxton KKarl
4Griffin SSusan

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Health ExpendituresMajor topic
Health Status DisparitiesMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
England
Female
Humans
Infant
Male
Middle Aged
Organizational Case Studies
Quality-Adjusted Life Years
Socioeconomic Factors
State Medicine
Young Adult

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125908564Distributional Cost-Effectiveness Analysis: A Tutorial.Med Decis Making2016https://conductscience.org/library/papers/25908564PubMed
210544328Health care spending as determinants of health outcomes.Health Econ1999https://conductscience.org/library/papers/10544328PubMed
318767897Valuing health States for use in cost-effectiveness analysis.Pharmacoeconomics2008https://conductscience.org/library/papers/18767897PubMed
426787198How a universal health system reduces inequalities: lessons from England.J Epidemiol Community Health2016https://conductscience.org/library/papers/26787198PubMed
518767894The NICE cost-effectiveness threshold: what it is and what that means.Pharmacoeconomics2008https://conductscience.org/library/papers/18767894PubMed
625488707Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?Health Econ2015https://conductscience.org/library/papers/25488707PubMed
725692211Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.Health Technol Assess2015https://conductscience.org/library/papers/25692211PubMed
832441558Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts.Med Decis Making2020https://conductscience.org/library/papers/32441558PubMed
915483304Measures of health inequalities: part 2.J Epidemiol Community Health2004https://conductscience.org/library/papers/15483304PubMed
1028237196Using Cost-Effectiveness Analysis to Address Health Equity Concerns.Value Health2017https://conductscience.org/library/papers/28237196PubMed
1131511189Estimating the Marginal Productivity of the English National Health Service From 2003 to 2012.Value Health2019https://conductscience.org/library/papers/31511189PubMed
1228462255Does More Public Health Spending Buy Better Health?Health Serv Res Manag Epidemiol2015https://conductscience.org/library/papers/28462255PubMed
1331386646Assessment of Inequality Alongside Policy-oriented Trials: An Empirical Framework Based on the Case of Screening.Epidemiology2019https://conductscience.org/library/papers/31386646PubMed
1416429295The relationship between health care expenditure and health outcomes. Evidence and caveats for a causal link.Eur J Health Econ2006https://conductscience.org/library/papers/16429295PubMed
1530483412Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data.BMJ Glob Health2018https://conductscience.org/library/papers/30483412PubMed
1624865459The impact of NHS resource allocation policy on health inequalities in England 2001-11: longitudinal ecological study.BMJ2014https://conductscience.org/library/papers/24865459PubMed
173499669International cross-section analysis of the determination of mortality.Soc Sci Med1987https://conductscience.org/library/papers/3499669PubMed
1824811892NICE's cost-effectiveness range: should it be lowered?Pharmacoeconomics2014https://conductscience.org/library/papers/24811892PubMed
1929273843Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.Pharmacoeconomics2018https://conductscience.org/library/papers/29273843PubMed
20711980Health service 'input' and mortality 'output' in developed countries.J Epidemiol Community Health (1978)1978https://conductscience.org/library/papers/711980PubMed

See all 28 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
41539560Value-Based Pricing of Health Services With Health Equity Considerations.Value Health2026https://conductscience.org/library/papers/41539560PubMed
41533281A Method for Comparing Health Inequality Impact Magnitudes, with an Illustration for Hypothetical Treatments of 1336 Diseases.Pharmacoeconomics2026https://conductscience.org/library/papers/41533281PubMed
40329067Aggregate Distributional Cost-Effectiveness Analysis of Biologics for the Treatment of Ankylosing Spondylitis in Chile.Appl Health Econ Health Policy2025https://conductscience.org/library/papers/40329067PubMed
39327612Synthesized economic evidence on the cost-effectiveness of screening familial hypercholesterolemia.Glob Health Res Policy2024https://conductscience.org/library/papers/39327612PubMed
39261579Impact of Diagnosis-Related Groups (DRG) reform on cost homogeneity of treatment for patients with malignant tumours.Sci Rep2024https://conductscience.org/library/papers/39261579PubMed
38758291Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework.Pharmacoeconomics2024https://conductscience.org/library/papers/38758291PubMed
38555401An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.Eye (Lond)2024https://conductscience.org/library/papers/38555401PubMed
38448909An empirical ethics study of the coherence of NICE technology appraisal policy and its implications for moral justification.BMC Med Ethics2024https://conductscience.org/library/papers/38448909PubMed
37296369Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.Pharmacoeconomics2023https://conductscience.org/library/papers/37296369PubMed
37221341Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration.Appl Health Econ Health Policy2023https://conductscience.org/library/papers/37221341PubMed
36612824Challenges and Limitations in Distributional Cost-Effectiveness Analysis: A Systematic Literature Review.Int J Environ Res Public Health2022https://conductscience.org/library/papers/36612824PubMed
35767187Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study.Appl Health Econ Health Policy2022https://conductscience.org/library/papers/35767187PubMed
35493397Spatial and Temporal Differences in the Health Expenditure Efficiency of China: Reflections Based on the Background of the COVID-19 Pandemic.Front Public Health2022https://conductscience.org/library/papers/35493397PubMed
35173023Innovations in cost-effectiveness analysis that advance equity can expand its use in health policy.BMJ Glob Health2022https://conductscience.org/library/papers/35173023PubMed
34098791Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions.Med Decis Making2021https://conductscience.org/library/papers/34098791PubMed
32608317Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis.Med Decis Making2020https://conductscience.org/library/papers/32608317PubMed
32291596Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations.Pharmacoeconomics2020https://conductscience.org/library/papers/32291596PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DLAT1737PubTator's text mininghttps://conductscience.org/library/genes/1737

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32065026

GET https://conductscience.org/api/papers/v1/32065026/references?page=2